BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 38476644)

  • 1. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An insight into the diagnostic, prognostic, and taxanes resistance of double zinc finger and homeodomain factor
    Said R; Hernández-Losa J; Jenni R; de Haro RSL; Moline T; Zouari S; Blel A; Rammeh S; Derouiche A; Ouerhani S
    3 Biotech; 2024 Apr; 14(4):106. PubMed ID: 38476644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-expression of Twist and Snai1: predictor of poor prognosis and biomarker of treatment resistance in untreated prostate cancer.
    Said R; Hernández-Losa J; Moline T; de Haro RSL; Zouari S; Blel A; Rammeh S; Derouiche A; Ouerhani S
    Mol Biol Rep; 2024 Jan; 51(1):226. PubMed ID: 38281235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of androgen regulation of ZEB-1 and PSA in 22RV1 prostate cancer cells.
    Anose BM; LaGoo L; Schwendinger J
    Adv Exp Med Biol; 2008; 617():541-6. PubMed ID: 18497080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
    Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
    Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks.
    Soleymani L; Zarrabi A; Hashemi F; Hashemi F; Zabolian A; Banihashemi SM; Moghadam SS; Hushmandi K; Samarghandian S; Ashrafizadeh M; Khan H
    Curr Cancer Drug Targets; 2021; 21(9):749-767. PubMed ID: 34077345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Claudin-1 up-regulates the repressor ZEB-1 to inhibit E-cadherin expression in colon cancer cells.
    Singh AB; Sharma A; Smith JJ; Krishnan M; Chen X; Eschrich S; Washington MK; Yeatman TJ; Beauchamp RD; Dhawan P
    Gastroenterology; 2011 Dec; 141(6):2140-53. PubMed ID: 21878201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-A Major Cardiac Comorbidity With Implications on Cardiovascular Metabolism.
    Finke D; Heckmann MB; Frey N; Lehmann LH
    Front Physiol; 2021; 12():729713. PubMed ID: 34899373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of ZEB1 reverses cancer stem cell properties in prostate cancer cells.
    Pérez G; López-Moncada F; Indo S; Torres MJ; Castellón EA; Contreras HR
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer.
    Rebello RJ; Oing C; Knudsen KE; Loeb S; Johnson DC; Reiter RE; Gillessen S; Van der Kwast T; Bristow RG
    Nat Rev Dis Primers; 2021 Feb; 7(1):9. PubMed ID: 33542230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders.
    Di Gregorio J; Robuffo I; Spalletta S; Giambuzzi G; De Iuliis V; Toniato E; Martinotti S; Conti P; Flati V
    Front Cell Dev Biol; 2020; 8():607483. PubMed ID: 33409282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signatures.
    Vasaikar SV; Deshmukh AP; den Hollander P; Addanki S; Kuburich NA; Kudaravalli S; Joseph R; Chang JT; Soundararajan R; Mani SA
    Br J Cancer; 2021 Jan; 124(1):259-269. PubMed ID: 33299129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc finger E-box binding homeobox 1 and atherosclerosis: New insights and therapeutic potential.
    Li H; Zou J; Yu XH; Ou X; Tang CK
    J Cell Physiol; 2021 Jun; 236(6):4216-4230. PubMed ID: 33275290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Curious Case of ZEB1.
    Madany M; Thomas T; Edwards LA
    Discoveries (Craiova); 2018 Dec; 6(4):e86. PubMed ID: 32309604
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.